- 2015
-
Press releases - 18.02.2015
Severe asthma: gallopamil confirmed as a therapeutic approach
A team of Inserm researchers from the Cardio-Thoracic Research Centre of Bordeaux has demonstrated the clinical efficacy of gallopamil in 31 patients with severe asthma.
-
Press releases - 17.02.2015
FameLab: the scientific communication competition returns to France !
For the second consecutive year, FameLab, the international scientific communication competition organised by the British Council and its partners, is coming back to France !
-
What's on? - 17.02.2015
FameLab: the scientific communication competition returns to France !
For the second consecutive year, FameLab, the international scientific communication competition organised by the British Council and its partners, is coming back to France !Who is this competition for?Whether you are a young researcher, student or teacher of science, FameLab invites you to present your chosen subject for three minutes to a panel of professionals […]
-
Press releases - 16.02.2015
Foetal growth restriction (FGR): assessment and impact of screening
An observational study carried out in France by Jennifer Zeitlin and her team, on over 14,000 women, shows that only 21% of infants with foetal growth restriction (FGR) had been suspected of having FGR during pregnancy.
-
Press releases - 13.02.2015
Immune cells commit suicide to prevent allergy
Scientists from the CNRS, INSERM and Université de Limoges have demonstrated that the production of type E immunoglobulins (IgE) by B lymphocytes induces a loss in their mobility and the initiation of cell death mechanisms.
-
Press releases - 11.02.2015
Tous Chercheurs: Experiencing science in order to better understand their disease
The ‘Tous Chercheurs’ association arranges an average of seven practical training courses in biology per year, each one lasting three days, for people affected by chronic diseases
-
Press releases - 10.02.2015
Choc Santé (Health Shock): Inserm is releasing a collection of books for the general public.
In partnership with Muscadier publishing house, Inserm is creating a series of books to inform the public about health matters.
-
What's on? - 06.02.2015
Monday 9 February 2015: World Epilepsy Day
Epilepsy is the spontaneous occurrence of epileptic fits, resulting from abnormal and simultaneous discharge of thousands of neurons[1]. Individuals affected by epilepsy can suffer severe physical and psychological side-effects, particularly caused by the unpredictability of the fits (injuries, problems of attentiveness, etc.). A large number of events have been organised for World Epilepsy Day, particularly […]
-
News in brief - 05.02.2015
Drug abuse and depression: towards a new understanding of brain mechanisms
Withdrawal, experienced by people when they stop using addictive drugs such as cocaine, induces states of anxiety and depression. This process makes the individual want to take the substance again, and thus plays a role in the establishment of drug addiction. The depressive syndrome thus represents an additional obstacle to be overcome when addicts are […]
-
Press releases - 04.02.2015
Towards a new weapon against muscular dystrophy
Research efforts associating scientists from the CNRS, UVSQ and INSERM within the Laboratoire END-ICAP, working in collaboration with a team from the University of Bern, has demonstrated the therapeutic potential of a new class of synthetic oligonucleotides in the treatment of Duchenne muscular dystrophy using RNA “surgery”.